RXPA 380 is a C-terminal specific angiotensin-converting enzyme ( ACE ) inhibitor with a K i of 3 nM. RXPA 380 inhibits C-domain mutants of human recombinant ACE with an IC 50 of 2.5 nM.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Angiotensin-converting Enzyme (ACE)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.